Medipharm Labs Stock Forward View - Relative Strength Index
| LABS Stock | CAD 0.07 0.01 6.67% |
Medipharm Stock outlook is based on your current time horizon. Although Medipharm Labs' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Medipharm Labs' systematic risk associated with finding meaningful patterns of Medipharm Labs fundamentals over time.
The relative strength index (RSI) of Medipharm Labs' share price is below 30 as of today. This indicates that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Medipharm Labs Corp, making its price go up or down. Momentum 21
Sell Stretched
Oversold | Overbought |
EPS Estimate Current Year (0.02) | Wall Street Target Price 0.1 | Quarterly Revenue Growth 0.168 |
Using Medipharm Labs hype-based prediction, you can estimate the value of Medipharm Labs Corp from the perspective of Medipharm Labs response to recently generated media hype and the effects of current headlines on its competitors.
Medipharm Labs after-hype prediction price | CAD 0.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medipharm |
Medipharm Labs Additional Predictive Modules
Most predictive techniques to examine Medipharm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medipharm using various technical indicators. When you analyze Medipharm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 21.11 | 21.11 |
| Check Medipharm Labs Volatility | Backtest Medipharm Labs | Information Ratio |
Medipharm Labs Trading Date Momentum
| On March 02 2026 Medipharm Labs Corp was traded for 0.07 at the closing time. The highest price during the trading period was 0.07 and the lowest recorded bid was listed for 0.07 . There was no trading activity during the period 0.0. Lack of trading volume on March 2, 2026 did not cause price change. The trading delta at closing time to the current price is 7.14% . |
| Compare Medipharm Labs to competition |
Other Forecasting Options for Medipharm Labs
For every potential investor in Medipharm, whether a beginner or expert, Medipharm Labs' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Medipharm Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Medipharm. Basic forecasting techniques help filter out the noise by identifying Medipharm Labs' price trends.Medipharm Labs Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medipharm Labs stock to make a market-neutral strategy. Peer analysis of Medipharm Labs could also be used in its relative valuation, which is a method of valuing Medipharm Labs by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Medipharm Labs Market Strength Events
Market strength indicators help investors to evaluate how Medipharm Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medipharm Labs shares will generate the highest return on investment. By undertsting and applying Medipharm Labs stock market strength indicators, traders can identify Medipharm Labs Corp entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0667 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.0725 | |||
| Day Typical Price | 0.0717 | |||
| Market Facilitation Index | 0.005 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 21.11 |
Medipharm Labs Risk Indicators
The analysis of Medipharm Labs' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Medipharm Labs' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting medipharm stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.44 | |||
| Semi Deviation | 3.65 | |||
| Standard Deviation | 5.26 | |||
| Variance | 27.7 | |||
| Downside Variance | 49.46 | |||
| Semi Variance | 13.33 | |||
| Expected Short fall | (8.36) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Medipharm Labs
The number of cover stories for Medipharm Labs depends on current market conditions and Medipharm Labs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Medipharm Labs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Medipharm Labs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Medipharm Labs Short Properties
Medipharm Labs' future price predictability will typically decrease when Medipharm Labs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Medipharm Labs Corp often depends not only on the future outlook of the potential Medipharm Labs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medipharm Labs' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 408 M | |
| Cash And Short Term Investments | 11.7 M |
Other Information on Investing in Medipharm Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.